161 related articles for article (PubMed ID: 38930917)
1. The Molecular Mechanisms of Cuproptosis and Small-Molecule Drug Design in Diabetes Mellitus.
Pan Z; Huang L; Gan Y; Xia Y; Yu W
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930917
[TBL] [Abstract][Full Text] [Related]
2. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
3. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
[TBL] [Abstract][Full Text] [Related]
4. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
[TBL] [Abstract][Full Text] [Related]
5. Cuproptosis: potential new direction in diabetes research and treatment.
Qu J; Wang Y; Wang Q
Front Endocrinol (Lausanne); 2024; 15():1344729. PubMed ID: 38904034
[TBL] [Abstract][Full Text] [Related]
6. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex.
Xu S; Hao Y; Xu X; Huang L; Liang Y; Liao J; Yang JR; Zhou Y; Huang M; Du KZ; Zhang C; Xu P
J Med Chem; 2024 May; 67(10):7911-7920. PubMed ID: 38709774
[TBL] [Abstract][Full Text] [Related]
8. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis: Mechanism, role, and advances in urological malignancies.
Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
[TBL] [Abstract][Full Text] [Related]
10. Dissecting copper homeostasis in diabetes mellitus.
Lowe J; Taveira-da-Silva R; Hilário-Souza E
IUBMB Life; 2017 Apr; 69(4):255-262. PubMed ID: 28276155
[TBL] [Abstract][Full Text] [Related]
11. 6-Hydroxydopamine disrupts cellular copper homeostasis in human neuroblastoma SH-SY5Y cells.
Kondo M; Hara H; Kamijo F; Kamiya T; Adachi T
Metallomics; 2021 Jul; 13(7):. PubMed ID: 34185060
[TBL] [Abstract][Full Text] [Related]
12. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
13. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
[TBL] [Abstract][Full Text] [Related]
14. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
Yuan HJ; Xue YT; Liu Y
Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
[TBL] [Abstract][Full Text] [Related]
16. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
Yang L; Yang P; Lip GYH; Ren J
Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
[TBL] [Abstract][Full Text] [Related]
17. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
Feng Y; Yang Z; Wang J; Zhao H
Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis: p53-regulated metabolic cell death?
Xiong C; Ling H; Hao Q; Zhou X
Cell Death Differ; 2023 Apr; 30(4):876-884. PubMed ID: 36755067
[TBL] [Abstract][Full Text] [Related]
19. Redox Homeostasis Disruptors Based on Metal-Phenolic Network Nanoparticles for Chemo/Chemodynamic Synergistic Tumor Therapy through Activating Apoptosis and Cuproptosis.
Zhao F; Yu H; Liang L; Wang C; Shi D; Zhang X; Ying Y; Cai W; Li W; Li J; Zheng J; Qiao L; Che S; Yu J
Adv Healthc Mater; 2023 Nov; 12(29):e2301346. PubMed ID: 37369362
[TBL] [Abstract][Full Text] [Related]
20. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge.
Song W; Yue Y; Zhang Q; Wang X
Front Physiol; 2024; 15():1243629. PubMed ID: 38883186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]